Barry S. Ticho

2022

In 2022, Barry S. Ticho earned a total compensation of $2.4M as Chief Medical Officer at Stoke Therapeutics, a 24% decrease compared to previous year.

Compensation breakdown

Bonus$20,712
Non-Equity Incentive Plan$186,407
Option Awards$1,697,431
Salary$470,723
Other$10,984
Total$2,386,257

Ticho received $1.7M in option awards, accounting for 71% of the total pay in 2022.

Ticho also received $20.7K in bonus, $186.4K in non-equity incentive plan, $470.7K in salary and $11K in other compensation.

Rankings

In 2022, Barry S. Ticho's compensation ranked 1,519th out of 5,753 executives tracked by ExecPay. In other words, Ticho earned more than 73.6% of executives.

ClassificationRankingPercentile
All
1,519
out of 5,753
74th
Division
Manufacturing
769
out of 3,133
76th
Major group
Chemicals And Allied Products
300
out of 1,419
79th
Industry group
Drugs
278
out of 1,320
79th
Industry
Pharmaceutical Preparations
198
out of 966
80th
Source: SEC filing on September 28, 2023.

Ticho's colleagues

We found two more compensation records of executives who worked with Barry S. Ticho at Stoke Therapeutics in 2022.

2022

Edward Kaye

Stoke Therapeutics

Chief Executive Officer

2022

Stephen Tulipano

Stoke Therapeutics

Chief Financial Officer

News

In-depth

You may also like